Pathological aspects of prostate cancer aggressive behavior. Personal experience in differentiating data

Area of Science:

• Uropathology
• Cancer Diagnostics
• Prostate Cancer Research

Background:

• Prostate-specific antigen (PSA) screening places a significant diagnostic and logistical burden on pathologists.
• The increasing detection of organ-confined prostate cancer complicates staging and prognosis.
• Current TNM staging (2002) for prostate cancer is inadequate, misclassifying tumor volume and prognosis.

Purpose of the Study:

• To highlight the diagnostic challenges in prostate biopsies, including distinguishing cancer from atrophic lesions.
• To critique the limitations of the current TNM staging system for prostate cancer.
• To identify key genetic markers associated with prostate cancer.

Main Methods:

• Review of common prostate biopsy lesions and diagnostic pitfalls.
• Analysis of the TNM staging system (2002) for prostate cancer.
• Discussion of proliferation markers and chromosomal abnormalities in prostate cancer.

Main Results:

• Atrophic areas, mimicking cancer in up to 90% of biopsies, pose a diagnostic challenge for inexperienced pathologists.
• The TNM staging system inaccurately classifies tumors, e.g., pT2b vs. pT2c, irrespective of tumor volume and prognosis.
• The long arm of chromosome 8 (8q24) is a frequent chromosomal marker in prostate cancer genesis and progression.

Conclusions:

• Pathologists face significant challenges in diagnosing prostate cancer due to biopsy volume and mimic lesions.
• The current TNM staging system for prostate cancer requires urgent revision for clinical utility.
• Understanding genetic markers like 8q24 is crucial for advancing prostate cancer diagnosis and treatment.